Clinical trial Recruiting at 1 site Observational Ages 18 to 100

Follow-up on upper limb transplant patients

Official title: Human Upper Extremity Allotransplantation: Transplanted Patient Follow-Up Protocol

Run by Johns Hopkins University · NCT03400345 · Data updated 2026-11-12

This study looks at how well upper limb transplants are working for patients who had the surgery at least five years ago, focusing on their safety and quality of life.

Quick facts

Study typeObservational
Ages18 Years to 100 Years
SexAll
Enrollment60 (estimated)
SponsorJohns Hopkins University
Academic / other
Locations1 site (Baltimore, Maryland)
StatusRecruiting
StartedJuly 25, 2017
Main results expectedJuly 30, 2036
Study endsJuly 30, 2036
Registry record updatedMay 11, 2026
Trial IDNCT03400345 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals who are at least five years post-unilateral or bilateral upper limb transplantation.

Probably not a fit

Patients who have not received an upper extremity allotransplant will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients who have undergone upper extremity allotransplantation, a procedure that is gaining traction in the U.S. The Johns Hopkins Hand/Arm Transplantation Team aims to collect ongoing data to assess the safety of the procedure and the effectiveness of the immunosuppression protocol. By enrolling patients who are at least five years post-transplant, the study seeks to quantify patient outcomes and improvements in quality of life over time.

Why it matters

Potential benefit: If successful, this study could enhance the understanding of upper limb transplantation and improve patient care and outcomes.

How similar studies have gone: While upper extremity allotransplantation is a relatively new field, ongoing data collection is crucial for understanding its long-term effects, and similar studies have shown promise in improving patient outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Males and females 5 or more years post-unilateral or bilateral upper limb transplantation.
* Completes the protocol informed consent form.
* Consents to sample collection and storage (biopsies).
* USA citizen or equivalent.
* Patient agrees to comply with the protocol and states a dedication to the immunomodulatory treatment regime.

Exclusion Criteria:

* Candidate has not received an upper extremity allotransplant.
* Any reason the study team thinks would cause the participant to be noncompliant or would put the patient at unacceptable risk if enrolled.

Where it's running

  • Johns Hopkins University School of Medicine
    Baltimore, Maryland, United States
    Recruiting

Study contacts

  • Principal investigator: Damon Cooney, M.D., Ph.D. — Johns Hopkins University
  • Study coordinator: Jane Littleton, C.R.N.P
  • Email: jlittl38@jhmi.edu
  • Phone: 410-955-6875

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.